ERASLAN, E. Et Al. 2018. Can Insulin-Like Protein-3 and Adropin be a New Marker in Hepatocellular Carcinoma?. ACTA PHYSIOLOGICA , vol.225 , 34.

ERASLAN, E., TOPDAĞI, Ö., TANYELİ, A., GÜLER, M. C., Sebin, E., ÖZBEK ŞEBİN, S., ... Polat, E.(2018). Can Insulin-Like Protein-3 and Adropin be a New Marker in Hepatocellular Carcinoma?. ACTA PHYSIOLOGICA , vol.225, 34.

ERASLAN, ERSEN Et Al. "Can Insulin-Like Protein-3 and Adropin be a New Marker in Hepatocellular Carcinoma?," ACTA PHYSIOLOGICA , vol.225, 34, 2018

ERASLAN, ERSEN Et Al. "Can Insulin-Like Protein-3 and Adropin be a New Marker in Hepatocellular Carcinoma?." ACTA PHYSIOLOGICA , vol.225, pp.34, 2018

ERASLAN, E. Et Al. (2018) . "Can Insulin-Like Protein-3 and Adropin be a New Marker in Hepatocellular Carcinoma?." ACTA PHYSIOLOGICA , vol.225, p.34.

@article{article, author={ERSEN ERASLAN Et Al. }, title={Can Insulin-Like Protein-3 and Adropin be a New Marker in Hepatocellular Carcinoma?}, journal={ACTA PHYSIOLOGICA}, year=2018, pages={34} }